Uomdannet dasatinib stod for henholdsvis 0, 1% og 19% af dosis i urin og fæces, mens resten af dosis var metabolitter.
Unchanged dasatinib accounted for 0.1% and 19% of the dose in urine and faeces, respectively, with the remainder of the dose as metabolites.